Emisphere Technologies Inc (EMIS)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Employees:
6
240 CEDAR KNOLLS RD., SUITE 200, CEDAR KNOLLS, NJ 07927
973-532-8000

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 480.497 Million Shares Outstanding84.15 Million Avg 30-day Volume 82.452 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.04
Price to Revenue26.4883 Debt to Equity-0.4386 EBITDA9.478 Million
Price to Book Value0.0 Operating Margin-595.5939 Enterprise Value91.104 Million
Current Ratio0.784 EPS Growth0.375 Quick Ratio0.742
1 Yr BETA 1.0895 52-week High/Low 0.0 / Profit Margin-205.7471
Operating Cash Flow Growth-284.2176 Altman Z-Score-144.8801 Free Cash Flow to Firm -12.772 Million
View SEC Filings from EMIS instead.

View recent insider trading info

Funds Holding EMIS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EMIS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2017-05-23:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2017-05-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-03-29:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-12-09:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-12-02:
    Item 8.01: Other Events
  • 8-K: filed on 2016-11-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-11-04:
    Item 8.01: Other Events
  • 8-K: filed on 2016-10-13:
    Item 8.01: Other Events
  • 8-K: filed on 2016-09-15:
    Item 8.01: Other Events
  • 8-K: filed on 2016-08-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    RACHESKY MARK H MD

    MHR CAPITAL PARTNERS MASTER ACCOUNT LP

    MHR ADVISORS LLC

    MHR INSTITUTIONAL PARTNERS II LP

    MHR INSTITUTIONAL PARTNERS IIA LP

    MHR INSTITUTIONAL ADVISORS II LLC

    MHRC LLC

    MHRC II LLC

    MHR FUND MANAGEMENT LLC

    MHR HOLDINGS LLC

    • Director
    • 10% Owner
    0 2017-06-30 0

    ROTHWELL TIMOTHY G

    • Director
    0 2017-05-18 0

    RACHESKY MARK H MD

    • Director
    • 10% Owner
    0 2017-05-18 0

    WEISER MICHAEL

    • Director
    0 2017-05-18 0

    MCINERNEY TIMOTHY

    • Director
    0 2017-05-18 0

    HARKEY JOHN D JR

    • Director
    0 2017-05-18 0

    PLOTSKER JACOB M

    • Director
    0 2017-05-18 0

    RUBINO ALAN L CEO

    • Officer
    0 2017-01-24 0

    GALLANTAR ALAN V INTERIM CFO

    • Officer
    0 2016-06-22 0

    GARONE MICHAEL CFO

    • Officer
    0 2016-01-14 0

    RACHESKY MARK H MD

    MHR CAPITAL PARTNERS MASTER ACCOUNT LP

    MHR ADVISORS LLC

    MHR INSTITUTIONAL PARTNERS II LP

    MHR INSTITUTIONAL PARTNERS IIA LP

    MHR INSTITUTIONAL ADVISORS II LLC

    MHR FUND MANAGEMENT LLC

    MHR HOLDINGS LLC

    • Director
    • 10% Owner
    0 2012-12-31 0

    MHRC LLC

    • 10% Owner
    7,073,179 2012-12-31 0

    MHRC II LLC

    • 10% Owner
    11,405,186 2012-12-31 0

    RILEY GARY SEE REMARKS

    • Officer
    0 2012-05-31 0

    RACHESKY MARK H MD

    MHR CAPITAL PARTNERS MASTER ACCOUNT LP

    MHR ADVISORS LLC

    MHR INSTITUTIONAL PARTNERS II LP

    MHR INSTITUTIONAL PARTNERS IIA LP

    MHR INSTITUTIONAL ADVISORS II LLC

    MHR FUND MANAGEMENT LLC

    • Director
    • 10% Owner
    0 2011-12-31 0

    MHR INSTITUTIONAL PARTNERS II LP

    MHR FUND MANAGEMENT LLC

    MHR INSTITUTIONAL ADVISORS II LLC

    RACHESKY MARK H MD

    • Director
    • 10% Owner
    2,412,718 2010-08-26 0

    RACHESKY MARK H MD

    MHR CAPITAL PARTNERS MASTER ACCOUNT LP

    MHR ADVISORS LLC

    MHR INSTITUTIONAL PARTNERS IIA LP

    MHR INSTITUTIONAL ADVISORS II LLC

    MHR FUND MANAGEMENT LLC

    • Director
    • 10% Owner
    0 2010-06-30 0

    NOVINSKI MICHAEL V CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    0 2010-03-10 0

    MOCH KENNETH I

    • Director
    0 2009-05-15 0

    BERGER FRANKLIN M

    • Director
    0 2009-05-15 0

    CARTER STEPHEN K

    • Director
    11,107 2008-08-13 0

    PACK HOWARD M

    • Director
    101,470 2008-08-13 0

    LUBETKIN PAUL VP AND GENERAL COUNSEL

    • Officer
    0 2007-09-11 0

    KRAGIE LAURA VP OF CLINICAL DEVELOPMENT,CMO

    • Officer
    0 2007-09-11 0

    GOLDBERG MICHAEL M

    • Director
    254,218 2007-08-22 0

    BENDER LEWIS H SENIOR VICE PRESIDENT

    • Officer
    28,444 2006-12-28 0

    RUMBLE WILLIAM PRINCIPAL ACCOUNTING OFFICER

    • Officer
    0 2006-08-14 0

    RACHESKY MARK H MD

    MHR ADVISORS LLC

    MHR INSTITUTIONAL ADVISORS II LLC

    MHR CAPITAL PARTNERS MASTER ACCOUNT LP

    • Director
    • 10% Owner
    617,211 2006-04-07 0

    RACHESKY MARK H MD

    MHR ADVISORS LLC

    MHR CAPITAL PARTNERS (500) LP

    • Director
    • 10% Owner
    15,077,917 2006-01-30 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments